Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects?
Stulc
Tomas
T
3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. tstulc@lf1.cuni.cz
Sedo
Aleksi
A
D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents; D007107:Immune System / Q000187:drug effects*; D054795:Incretins; D009369:Neoplasms / Q000139:chemically induced*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D054795:Incretins